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mide, 3 with phenobarbital, 3 with clonazepam, 2 with me- 
suximide, and 1 with ethadione. 
The results of biotin analysis in epileptics were compared 
with biotin plasma levels for 93 controls (blood donors and 
patients with dermatological diseases) who had a mean age 
of 42 years. Statistical analysis between groups was carried 
out using the Student t test. 
In 264 epileptics undergoing long-term therapy with 
anticonvulsants, significantly reduced plasma biotin 
levels were found compared with a normal control 
group: 74% of the epileptics had biotin levels of 250 
ngIL or less. In patients undergoing single-drug 
therapy, the mean plasma biotin levels for those 
treated with sodium valproate were higher than for 
those treated with phenytoin, primidone, or car- 
bamazepine. The observed reduction in biotin levels 
might be a factor influencing the efficacy of these three 
anticonvulsants. 
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Recently we reported reduced plasma biotin levels in 
epileptics undergoing long-term therapy with an- 
ticonvulsants [5]. The plasma biotin levels showed a 
significant negative correlation with the total amount 
and average daily dose of anticonvulsants adminis- 
tered. Because of the small number of patients ex- 
amined, no differentiation of the effect of single an- 
ticonvulsants could be made. Subsequently, we have 
investigated 264 patients. 
Methods 
Plasma biotin concentrations were determined micro- 
biologically using Lactobacillus plantarum as a test or- 
ganism, as described by Frigg and Brubacher [4].  The 
plasma biotin levels of 264 epileptics aged 20 to 40 years 
were measured. Each had received anticonvulsant therapy 
for at least one year. At the time of examination 135 pa- 
tients were taking several anticonvulsants in combination, 
mostly phenytoin with carbamazepine (N  = 29), primidone 
(N = 21), phenobarbital (N = 19), or a combination of 
primidone with either sodium valproate (N  = 16) or car- 
bamazepine (N = 13). One hundred twenty-nine epiIeptics 
were receiving single-drug therapy: 40 with primidone, 3 1 
with phenytoin, 25 with carbamazepine, 12 with sodium 
valproate, 8 with CHP-phenobarbital, 4 with ethosuxi- 
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Results 
The mean plasma biotin level in epileptics (227 t 80 
ng/L) was significantly lower (p < 0.0005) than that 
in controls (448 5 201 ng/L). Seventy-four percent 
of the epileptics had a biotin level of 2 50 ng/L or  less; 
only 1 control had a level as low as 250 ng/L (Figure). 
The plasma biotin level (mean t SD) in the 135 
epileptics undergoing combination therapy was re- 
duced to 231 -+ 76 ng/L (p < 0.0005 compared to 
the controls). The mean plasma biotin levels in pa- 
tients undergoing single-drug anticonvulsant therapy 
with phenytoin, primidone, carbamazepine, or 
sodium valproate are shown in the Table. The 
epileptics taking sodium valproate had a slightly 
lower mean plasma biotin level than the controls (p 
< 0.05) but significantly higher levels than patients 
treated with other single anticonvulsants (phenytoin, 
p < 0.01; carbamatepine,p < 0.01; primidone,p < 
0.001). The plasma biotin levels in patients taking 
these three anticonvulsants were significantly lower 
than in the controls (p < 0.0005 in each case). 
Discussion 
The previously reported reduction of biotin plasma 
levels in epileptics undergoing anticonvulsant treat- 
ment [ 51 has been impressively affirmed. Considering 
that epileptics treated with phenytoin, primidone, o r  
carbamazepine had significantly lower plasma biotin 
levels than those treated with sodium valproate, the 
question arises whether the reduction in biotin levels 
might be a factor in the efficacy of these drugs. A 
reduction of the biotin-dependent pyruvate car- 
boxylase may cause a reduced level of aspartate via 
the decrease of oxalacetate. A decline of this neuro- 
transmitter in the brain, caused by phenytoin intake, 
has recently been demonstrated in animals [6]. 
Dermatitis and ataxia are clinical manifestations of 
an inborn error of biotin-dependent enzymes [l-3,  
7, 81. It is of interest that these symptoms are well- 
known side effects of anticonvulsants, with the ex- 
ception of sodium valproate. On the other hand, sei- 
zures have been reported in some cases of an inborn 
error of biotin-dependent enzymes [l, 3 ,  81. Al- 
together, the implication of the reported decline of 
biotin levels under anticonvulsant treatment is not 
clear. The pharmacological effect of biotin deficiency 
in epileptics deserves further attention. 
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Plasma Biotin Levels in Epileptics Receiving Single-Drug Therapy 
Anticonvulsant No. of Patients Biotin (ndL,  mean 2 SD)  
31 2 2 0  * 69 Phenytoin 
Carbamazepine 2 5  2 1 8  t 59 
Sodium valproate 12 340 * 171  
Primidone 40 201  t 55 
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con trols epileptics 
Plasma biotin levels in' epileptics receiving long-term anticon- 
vulsant therapy (N = 264) and in  controls (N = 93). 
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Correlation of Isotopic 
Cisternographic Patterns 
in Multiple Sclerosis 
with CSF IgG Values 
S. Bartolini, MD,* D .  Inzitari, MD," 
A. Castagnoli, M D , t  and L. Amaducci, MD" 
T h i r t y - e i g h t  patients with multiple sclerosis (MS) 
were examined with isotopic  c i s t e rnography  (IC) in 
order to s t u d y  cerebrospinal fluid (CSF) dynamics.  Cis- 
t e r n o g r a p h y  was also performed in 15 patients with 
a m y o t r o p h i c  lateral sclerosis and in 14 with senile de- 
mentia of the Alzhe imer  t y p e  as controls. IC pattern of 
"mixed" t y p e  was found in 18 MS patients and all those 
with Alzhe imer  senile dementia examined, while the 
IC examination did not show abnorma l i ty  in a n y  of 
15 patients with amyot roph ic  lateral sclerosis. In 
MS patients, the abnormal IC picture proved to be 
signif icant ly  co r re l a t ed  with the CSF IgG values as cal- 
culated b y  Link's and Tourtelotte's formulas. The ab- 
normal IC in MS ]may be due to altered CSF reabsorp- 
tion or increased t r ansependymal  flow, or it m a y  be 
related to the a b n o r m a l  concentration of IgG. 
Bartolini S, Inzitari D, Castagnoli A, Amaducci L: 
Correlation of isotopic cisternographic patterns in 
multiple sclerosis with CSF IgG values. 
A n n  Neurol  12:486-489, 1982 
In recent years,  m a n y  investigators have utilized 
isotope c i s t e rnography  (IC) to evaluate the formation 
and absorption of cerebrospinal fluid (CSF) [2-41. 
Attempts to correlate the results of isotope tests with 
various disease st ,ates have not always produced con- 
sistent associatioins. Nevertheless, certain patterns 
have been a t t r i b u t e d  to the presence of in f l ammato ry  
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